Article Information
History
- December 7, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Eloi Gagnon1,*,
- Arnaud Girard1,*,
- Jérôme Bourgault1,
- Erik Abner1,
- Estonian Biobank Research Team,
- Dipender Gill3,
- Sébastien Thériault1,4,
- Marie-Claude Vohl5,6,
- André Tchernof1,5,
- Tõnu Esko2,
- Patrick Mathieu1,7 and
- Benoit J. Arsenault, PhD1,8,**
- 1Centre de recherche de l’Institut universitaire de cardiologie et de pneumologie de Québec, Québec (QC), Canada
- 2Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu, Estonia
- 3Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, (London), United Kingdom
- 4Department of Molecular Biology, Medical Biochemistry and Pathology, Faculty of Medicine, Université Laval, Québec (QC), Canada
- 5School of Nutrition, Université Laval, Québec (QC), Canada
- 6Centre Nutrition, santé et société (NUTRISS), Institut sur la nutrition et les aliments fonctionnels (INAF), Université Laval, Québec (QC), Canada
- 7Department of Surgery, Faculty of Medicine, Université Laval, Québec (QC), Canada
- 8Department of Medicine, Faculty of Medicine, Université Laval, Québec (QC), Canada
- ↵**Address for correspondence Benoit Arsenault, PhD Centre de recherche de l’Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval Y-3106, Pavillon Marguerite D’Youville, 2725 chemin Ste-Foy, Québec (QC) Canada G1V 4G5 Telephone: 418-656-8711 ext. 3498 Email: benoit.arsenault{at}criucpq.ulaval.ca
↵* These two authors contributed equally.
Posted December 07, 2023.
Genetic assessment of efficacy and safety profiles of coagulation cascade proteins identifies Factors II and XI as actionable anticoagulant targets
